Posts Tagged Pharmaceuticals
OSI Pharmaceuticals, Inc. announced that it has completed enrollment in the RADIANT study, a Phase III clinical trial testing Tarceva (erlotinib) as an adjuvant therapy in patients with Stage IB-IIIA non- small cell lung cancer (NSCLC) who have undergone surgery and have EGFR-positive tumors.
Source: General Cancer News Articles Provided by Cancer [...]
Tags:
Adjuvant,
Announces,
Cancer,
Cell,
Completes,
Enrollment,
International,
Lung,
NonSmall,
Pharmaceuticals,
Phase,
RADIANT,
Tarceva,
Trial Posted in
Cancer on | There are currently
No Comments
Merrimack Pharmaceuticals, Inc. announced that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva?? (erlotinib) in patients with non- small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as [...]
Tags:
Cancer,
Cell,
Combination,
Enrollment,
Initiates,
Lung,
Merrimack,
MM121,
NonSmall,
patients,
Pharmaceuticals,
Phase,
Study,
Tarceva Posted in
Cancer on | There are currently
No Comments
Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2- 391 in patients with bone-metastatic, castrate- resistant prostate cancer (CRPC) who have not had prior chemotherapy.
Source: General Cancer News Articles Provided by Cancer Compass